This study tests a new medicine called KAI-9531 (ribupatide) given as a weekly shot to help people with obesity lose weight. It includes 250 adults who have a BMI of 35 or higher and have tried to lose weight before without success. Participants will receive either the drug or a …
Phase: PHASE2 • Sponsor: Kailera • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC